Volume 35, Issue 244 (5-2025)
J Mazandaran Univ Med Sci 2025, 35(244): 104-113 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini S H, Khadem haghighian H, Yari Sarokolae Z, Arab firozjae A, Bayat S, Eshaghi Gorji R, et al . Investigating the Effect of Gallic Acid on Serum BDNF Levels in Patients with Major Depression. J Mazandaran Univ Med Sci 2025; 35 (244) :104-113
URL: http://jmums.mazums.ac.ir/article-1-20857-en.html
URL: http://jmums.mazums.ac.ir/article-1-20857-en.html
Seyed Hamzeh Hosseini 
, Hossein Khadem haghighian , Zahra Yari Sarokolae , Atefeh Arab firozjae , Sara Bayat , Reza Eshaghi Gorji , Majid Saeedi , Gholamreza Houshmand
, Hossein Khadem haghighian , Zahra Yari Sarokolae , Atefeh Arab firozjae , Sara Bayat , Reza Eshaghi Gorji , Majid Saeedi , Gholamreza Houshmand
Abstract: (231 Views)
Background and purpose: Changes in Brain-Derived Neurotrophic Factor (BDNF) levels are associated with psychiatric disorders, including depression. Research has demonstrated that patients suffering from depression exhibit reduced BDNF levels, and antidepressant treatments have been shown to increase these levels. Gallic acid, a natural compound known for its antioxidant and neurotrophic properties, shows significant potential for enhancing BDNF levels and alleviating depressive symptoms. This study aims to investigate the effect of gallic acid supplementation on serum BDNF levels in patients diagnosed with depression.
Materials and methods: This study was conducted using serum samples obtained from our previous research involving 30 patients diagnosed with major depressive disorder who visited Shahid Zareh Hospital in Sari. The patients were randomly divided into two groups: an intervention group and a placebo group. Individuals in the intervention group received 200 mg of gallic acid daily in capsule form. Blood samples (10 cc) were collected from each participant at both the start and the end of the study. Following serum separation, the levels of BDNF in the plasma samples were measured using a specific ELISA kit.
Results: After the intervention, the findings showed a significant difference between the plasma BDNF levels of the research groups. The plasma BDNF levels in the intervention group increased significantly compared to the placebo group.
Conclusion: According to the results, gallic acid supplementation increases the level of BDNF, and this supplement may be used in conjunction with existing antidepressants to reduce the side effects of current drugs.
(Clinical Trials Registry Number: IRCT20141025019669N17
Materials and methods: This study was conducted using serum samples obtained from our previous research involving 30 patients diagnosed with major depressive disorder who visited Shahid Zareh Hospital in Sari. The patients were randomly divided into two groups: an intervention group and a placebo group. Individuals in the intervention group received 200 mg of gallic acid daily in capsule form. Blood samples (10 cc) were collected from each participant at both the start and the end of the study. Following serum separation, the levels of BDNF in the plasma samples were measured using a specific ELISA kit.
Results: After the intervention, the findings showed a significant difference between the plasma BDNF levels of the research groups. The plasma BDNF levels in the intervention group increased significantly compared to the placebo group.
Conclusion: According to the results, gallic acid supplementation increases the level of BDNF, and this supplement may be used in conjunction with existing antidepressants to reduce the side effects of current drugs.
(Clinical Trials Registry Number: IRCT20141025019669N17
Type of Study: Research(Original) |
Subject:
pharmacology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
